Users of this system, can login to view this document.
Login
Enter the following information to request a copy of the document from the responsible person.
Circulating microRNA Analysis in a Prospective Co-clinical Trial Identifies MIR652-3p as a Response Biomarker and Driver of Regorafenib Resistance Mechanisms in Colorectal Cancer.
This email address is used for sending the document.